The vaccine could replace multiple jabs every year for winter respiratory infections and may even work against new pandemic ...

More parents are skipping childhood vaccines after the COVID-19 pandemic as vaccines become a flashpoint in American politics and culture. The post How the search for vaccine safety led parents away ...

Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the ...

Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...

After public backlash, the FDA will review a new mRNA flu vaccine. That's good news, but its original rejection and other arbitrary decisions undermine U.S. leadership in biopharmaceutical innovation.

The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...

(THE CONVERSATION) The Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm of ...

The Trump administration has tapped National Institutes of Health (NIH) Director Jay Bhattacharya, MD, PhD, to temporarily oversee the Centers for Disease Control and Prevention (CDC), reports the New ...

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

Moderna's stock surges after the FDA said it would review the biotech's flu vaccine candidate, a week after it had refused to do so. Shares of Moderna surged Wednesday after the drugmaker got health ...

The Food and Drug Administration’s recent decision to turn away Moderna’s application for a new flu shot for older Americans is a troubling development in health officials’ piecemeal dismantling of ...

As Illinois experiences its most severe flu season in over a decade, public health officials report rising hospitalizations and lower ...